Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|February 3, 2023
Metal-Organic Framework in Pharmaceutical Drug DeliverySudipto Kundu, Akey Krishna Swaroop, Jubie SelvarajDrug Research|January 11, 2024
"In-silico Design and Development of Novel Hydroxyurea Lipid Drug Conjugates for Breast Cancer Therapy Targeting PI3K/AKT/mTOR Pathway"Saranya Dharmaraj, Akey Krishna Swaroop, Mariappan Esakkimuthukumar, et al.Current Drug Research Reviews|February 14, 2023
Thioredoxin Interacting Protein Inhibitors in Diabetes Mellitus: A Critical ReviewAyushi Kar, Balamurugan Paramasivam, Darshini Jayakumar, et al.Anti-Cancer Agents in Medicinal Chemistry|August 23, 2023
Effect of Calcitriol in Inhibiting the Cancer Cell Growth and Promoting Apoptosis in ErbB2-positive Breast Cancer CellsNagaraj Balan Selvaraj, Akey Krishna Swaroop, Esakkimuthukumar Mariappan, et al.Mini Reviews in Medicinal Chemistry|May 13, 2022
Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-ReviewSunil Kumar Patnaik, M J N Chandrasekar, Palathoti Nagarjuna, et al.Journal of Biomolecular Structure & Dynamics|May 9, 2023
Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulationsLavanya Mude, Srikanth Jupudi, Akey Krishna Swaroop, et al.Current Molecular Pharmacology|February 27, 2023
Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer ChemotherapySunil Kumar Patnaik, Akey Krishna Swaroop, Palathoti Nagarjuna, et al.Drug Research|April 17, 2023
Repurposing of FDA Approved Drugs and Neuropep peptides as Anticancer Agents Against ErbB1 and ErbB2Sunil Kumar Patnaik, Akey Krishna Swaroop, Mudavath Ravi Naik, et al.Current Drug Targets|July 7, 2026
Harnessing HIF-1α for Diabetic Wound Healing: From Molecular Insights to Therapeutic StrategiesEsakkimuthukumar Mariappan, Akey Krishna Swaroop, Saranya Rajanbabu, et al.Current Topics in Medicinal Chemistry|January 22, 2026
Formononetin-Celecoxib Conjugate as Matrix Metalloproteinase 9 Inhibitor for Osteoarthritis TherapySilpa Sivakumar, Akey Krishna Swaroop, Esakkimuthukumar Mariappan, et al.Pageof 2